top of page
Case Studies & Blogs
Raising the Bar: What EMA, FDA, and HTAs Want from Real-World Evidence Today
The use of real-world data in regulatory submissions is no longer novel. It is expected. But as agencies like the FDA and EMA signal...
May 13, 20252 min read
Spotting Patterns, Seeing Problems: Smarter Designs for Alzheimer’s Research
In a recent article, The Economist reported on an idea gaining traction in dementia research: that certain viral infections may help...
Apr 29, 20253 min read
Beyond Hindsight: How New Tools Help Anticipate Clinical Risks
Clinical trials, particularly in therapeutic areas like neurology and oncology, are ambitious ventures fraught with considerable...
Apr 15, 20253 min read
bottom of page